InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
61,830.08
(
1.54%
)
Post# of 252434
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

masterlongevity

Send PM Follow Ignore
Followers 25
Posts 2597
Boards Moderated 0
Alias Born 01/07/2004

masterlongevity

Re: genisi post# 153450

Monday, 12/03/2012 4:55:58 PM

Monday, December 03, 2012 4:55:58 PM

Post# of 252434
i knew they were doing a ph2/3, but was very surprised to see this in mild to moderate AD. I had heard that this trial would be in MCI due to AD.

My estimate is that it will take them 6 months to enroll 200 subjects. I would bet they will take this from a ph 2 to ph 3 after they have 1 yr of safety and Biomarker data on ~100 patients. so maybe a switch to phase 3 within 1.5 years from now.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up